Barely Significant
← all excerpts

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).

Vasc Health Risk Manag · 2006 · PMC1994022 · PMID 17323592

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp=0.001actually significant
Overall, pretreatment with clopidogrel resulted in a highly significant reduction in cardiovascular death, MI, or stroke from randomization through 30 days (7.5% clopidogrel vs 12.0% placebo; adjusted OR, 0.59, 95% CI: 0.43–0.81; p=0.001; number needed to treat = 23).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.